Prime Highlight SciNeuro Pharmaceuticals secured $53 million in equity financing, plus a $5 million research grant from The Michael J. Fox Foundation, to accelerate its

Prime Highlights: The UK and US have reached a breakthrough deal to keep tariffs at zero for all British pharmaceutical exports for the next three

Prime Highlights: Aurobindo Pharma is using Europe as a major growth market, expanding its presence across nine EU countries and the UK. The company has

Prime Highlights: Cellbyte secures $2.75 million in seed funding to develop an AI-driven platform for faster, smarter drug launches. The platform aims to help pharmaceutical

Prime Highlights: Aptamer Group secures a £617,000 contractwith a top five global pharmaceutical company, marking their third collaboration. The new multi-target programmeexpands the partnership and

Prime Highlights: ImmuPharma is in talks with several major pharmaceutical companies, including some of the world’s top ten, for its P140 autoimmune programme. The company

Prime Highlights Alvotech and Advanz Pharma have secured European Commission approval for Gobivaz, the first biosimilar to Simponi (golimumab) in the EEA. The companies aim

Prime Highlights: GSK has signed a $50 million deal with LTZ Therapeutics to develop new myeloid cell engager cancer treatments. The partnership allows GSK to

Prime Highlights:  Glenmark Pharma’s Q2 profit jumped 72.2%, boosting investor confidence and lifting the stock during early trade.  The company recorded major revenue from its licensing deal

Prime Highlight  Mursla Bio has partnered with a leading global pharmaceutical company to accelerate biomarker-guided drug development for metabolic dysfunction-associated steatohepatitis (MASH) using its AI Precision Medicine Platform.